- Christian Berghold1,3, Sereina Annik Herzog2,3, Heidelinde Jakse4, Andrea Berghold2
-
View Affiliations Hide AffiliationsAffiliations: 1 Labor Dr. Berghold, Graz, Austria 2 Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria 3 Both authors contributed equally as first authors 4 Mother-child booklet service, Styrian Health Insurance (Steiermärkische Gebietskrankenkasse), Graz, AustriaChristian Bergholdchristian.berghold gmx.net
-
View Citation Hide Citation
Citation style for this article: Berghold Christian, Herzog Sereina Annik, Jakse Heidelinde, Berghold Andrea. Prevalence and incidence of toxoplasmosis: a retrospective analysis of mother-child examinations, Styria, Austria, 1995 to 2012. Euro Surveill. 2016;21(33):pii=30317. https://doi.org/10.2807/1560-7917.ES.2016.21.33.30317 Received: 31 Jul 2015; Accepted: 19 Jan 2016
Prevalence and incidence of toxoplasmosis: a retrospective analysis of mother-child examinations, Styria, Austria, 1995 to 2012
Abstract
In Austria, mandatory screening for the prevention of congenital toxoplasmosis stipulates a serological test for antibodies against Toxoplasma gondii as early as possible in pregnancy. In the case of a seronegative result, subsequent tests at intervals of 8 weeks are requested. We analysed serological data from Styria, an Austrian federal state, to determine the seroprevalence and incidence of Toxoplasma infections. The study included 353,599 tests from 103,316 women during 158,571 pregnancies from 1995 to 2012. The age-adjusted seroprevalence decreased from 43.3% in 1995 to 31.5% in 2012, with a yearly decline of 0.84% (95% confidence interval (CI): 0. 79 -0.88). The intergravid incidence showed an annual decrease of 4.2%. The average yearly incidence of intragravid and intergravid seroconversions was 0.52% (95% CI 0.45–0.61) and 0.72% (95% CI 0.67–0.77), respectively. If the difference between these rates (p < 0.001) can be explained by the effect of primary prevention such as avoiding raw meat and taking hygiene precautions when encountering cats or preparing vegetables, only ca two of seven (28%) infections were avoided by hygiene measures taken by pregnant women. Primary prevention may therefore have its limits.

Article metrics loading...

-
From This Site
/content/10.2807/1560-7917.ES.2016.21.33.30317dcterms_title,dcterms_subject,pub_keyword105 -
PubMed
-
Google Scholar

Full text loading...
References
-
Moncada PA, Montoya JG. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther. 2012;10(7):815-28. https://doi.org/10.1586/eri.12.58 PMID: 22943404
-
Prusa A. on behalf of the Austrian working group on toxoplasmosis. Österreichische Richtlinie für das Toxoplasmose-Screening in der Schwangerschaft und frühen Kindheit. Screening, Therapie und kindliches Follow-up [Austrian guideline for toxoplasmosis screening in pregnancy and early childhood. Screening, treatment and follow-up of children]. Vienna: Austrian Society for Paediatrics; 2013. German. [Accessed 27 Jul 2015]. Available from: http://www.docs4you.at/Content.Node/Spezialbereiche/Infektiologie/TS/oesterreichische-Richtlinie-fuer-das-Toxoplasmose-Screening.php
-
Aspöck H, Husslein P, Janisch H, Möse JR, Pollak A, Vander-Möse A, et al. [Toxoplasmosis. Recommendations for treatment of primary toxoplasma infection in pregnancy and congenital toxoplasmosis]. Gynakol Geburtshilfliche Rundsch. 1994;34(1):50-1. PMID: 8019174
-
Prusa AR, Kasper DC, Pollak A, Gleiss A, Waldhoer T, Hayde M. The Austrian Toxoplasmosis Register, 1992-2008. Clin Infect Dis. 2015;60(2):e4-10. https://doi.org/10.1093/cid/ciu724 PMID: 25216688
-
Hotop A, Hlobil H, Gross U. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2012;54(11):1545-52. https://doi.org/10.1093/cid/cis234 PMID: 22460980
-
SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group,Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet. 2007;369(9556):115-22. https://doi.org/10.1016/S0140-6736(07)60072-5 PMID: 17223474
-
Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264-96. https://doi.org/10.1128/CMR.05013-11 PMID: 22491772
-
Hofhuis A, van Pelt W, van Duynhoven YTHP, Nijhuis CDM, Mollema L, van der Klis FR, et al. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiol Infect. 2011;139(4):530-8. https://doi.org/10.1017/S0950268810001044 PMID: 20492743
-
Jones JL, Kruszon-Moran D, Rivera HN, Price C, Wilkins PP. Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades. Am J Trop Med Hyg. 2014;90(6):1135-9. https://doi.org/10.4269/ajtmh.14-0013 PMID: 24710615
-
Sagel U, Krämer A, Mikolajczyk RT. Incidence of maternal Toxoplasma infections in pregnancy in Upper Austria, 2000-2007. BMC Infect Dis. 2011;11(1):348. https://doi.org/10.1186/1471-2334-11-348 PMID: 22168604
-
Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, et al. Toxosurv network and National Reference Centre for Toxoplasmosis. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 2010;15(25):19600. PMID: 20587361
-
Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91(7):501-8. https://doi.org/10.2471/BLT.12.111732 PMID: 23825877
-
Fricker-Hidalgo H, Cimon B, Chemla C, Dardé ML, Delhaes L, L’ollivier C, et al. Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study. J Clin Microbiol. 2013;51(7):2103-11. https://doi.org/10.1128/JCM.00169-13 PMID: 23616461
-
R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2015. Available from: http://www.R-project.org
-
Thalhammer O. [The diagnosis and therapy of a toxoplasmosis infection in pregnancy. Birth of a healthy child in sulfonamide-pyrimethamine-treated lymph node toxoplasmosis in the 4th and 5th month of pregnancy]. Dtsch Med Wochenschr. 1960;85:177-9. German. https://doi.org/10.1055/s-0028-1112415 PMID: 13837649
-
Larsen SO, Lebech M. Models for prediction of the frequency of toxoplasmosis in pregnancy in situations of changing infection rates. Int J Epidemiol. 1994;23(6):1309-14. https://doi.org/10.1093/ije/23.6.1309 PMID: 7721535
-
Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000;321(7254):142-7. https://doi.org/10.1136/bmj.321.7254.142 PMID: 10894691
-
van der Giessen J, Fonville M, Bouwknegt M, Langelaar M, Vollema A. Seroprevalence of Trichinella spiralis and Toxoplasma gondii in pigs from different housing systems in The Netherlands. Vet Parasitol. 2007;148(3-4):371-4. https://doi.org/10.1016/j.vetpar.2007.06.009 PMID: 17646053
-
National Institute for Health and Clinical Excellence (NICE). Antenatal Care: Routine Care for the Healthy Pregnant Woman. London: RCOG Press; 2008. [Accessed 30 Jul 2015] Available from: https://www.nice.org.uk/guidance/CG62
-
Gollub EL, Leroy V, Gilbert R, Chêne G, Wallon MEuropean Toxoprevention Study Group (EUROTOXO). Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2008;136(2):137-45. https://doi.org/10.1016/j.ejogrb.2007.09.010 PMID: 17977641
-
Krueger WS, Hilborn ED, Converse RR, Wade TJ. Drinking water source and human Toxoplasma gondii infection in the United States: a cross-sectional analysis of NHANES data. BMC Public Health. 2014;14(1):711. https://doi.org/10.1186/1471-2458-14-711 PMID: 25012250
-
Jones JL, Dubey JP. Waterborne toxoplasmosis--recent developments. Exp Parasitol. 2010;124(1):10-25. https://doi.org/10.1016/j.exppara.2009.03.013 PMID: 19324041
-
Prusa AR, Kasper DC, Olischar M, Husslein P, Pollak A, Hayde M. Evaluation of serological prenatal screening to detect Toxoplasma gondii infections in Austria. Neonatology. 2013;103(1):27-34. https://doi.org/10.1159/000342625 PMID: 23018152
-
Murat JB, Dard C, Fricker Hidalgo H, Dardé ML, Brenier-Pinchart MP, Pelloux H. Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns. Clin Vaccine Immunol. 2013;20(8):1203-12. https://doi.org/10.1128/CVI.00089-13 PMID: 23740928

Data & Media loading...
